R21/Matrix-M Malaria Vaccine Discovery: Paving the Way for a Malaria-Free Future

Published on May 1, 2024

Researchers from the University of Oxford will present new exciting data on the R21/Matrix-M malaria vaccine during the 8th Pan-African Malaria Conference, in collaboration with the Ministry of Health (MoH)-Rwanda and the Rwanda Biomedical Centre (RBC).
Continue reading on website
Other news

New study to improve vaccines and therapeutics development

May 1, 2024
A first-of-its-kind study led by the University of Oxford has successfully investigated human immunity against COVID-19 in people who already have antibodies against it.

Novel triple drug combination effective against antibiotic-resistant bacteria

May 2, 2024
Scientists at the Ineos Oxford Institute (IOI) have found a new potential combination therapy to combat antimicrobial resistance (AMR) by targeting two key bacterial enzymes involved in resistance. The findings have been published in the journal Engineering.